238 results
8-K
EX-99.1
PRTA
Prothena Corporation plc
8 May 24
Prothena Reports First Quarter 2024 Financial Results and Business Highlights
4:09pm
is responsible for all development, manufacturing, and commercialization of BMS-986446
PRX123, a wholly-owned potential first-in-class dual Aβ/tau vaccine … position of Chief People Officer in March 2024. In this role, Mr. Ford is responsible for people, culture, and human resources strategy to drive
S-3ASR
lis8664s vvvc
22 Feb 24
Automatic shelf registration
5:29pm
8-K
EX-99.1
dvl4q5m2yj2jm
15 Feb 24
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
4:09pm
UPLOAD
1hw90geshj4
23 Aug 23
Letter from SEC
12:00am